Antifungal Potential of Streptomyces-Derived Metabolites Against Fluconazole-Resistant Oral Candida albicans: In vitro Evaluation and Mechanistic Insights
Iranian Biomedical Journal · 2025
DOI: 10.61882/ibj.4937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Biomedical Journal, 2025. Verfasst von Mahtab Karami-Feli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mycology, Pasteur Institute of Iran, Tehran, Iran. Hauptthemen laut MEDLINE: Candida albicans, Antifungal Agents, Drug Resistance, Fungal, Streptomyces. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mycology, Pasteur Institute of Iran, Tehran, Iran.
- Department of Microbial Biotechnology, Agricultural Biotechnology Research Institute of Iran (ABRII), Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Zitieren
APA
Karami-Feli, M., Jahanshiri, Z., & Sadeghi, A. (2025). Antifungal Potential of Streptomyces-Derived Metabolites Against Fluconazole-Resistant Oral Candida albicans: In vitro Evaluation and Mechanistic Insights. Iranian Biomedical Journal. https://doi.org/10.61882/ibj.4937
Vancouver
Karami-Feli M, Jahanshiri Z, Sadeghi A. Antifungal Potential of Streptomyces-Derived Metabolites Against Fluconazole-Resistant Oral Candida albicans: In vitro Evaluation and Mechanistic Insights. Iranian Biomedical Journal. 2025. doi:10.61882/ibj.4937
BibTeX
@article{KaramiFeli2025,
author = {Karami-Feli, Mahtab and Jahanshiri, Zahra and Sadeghi, Akram},
title = {Antifungal Potential of Streptomyces-Derived Metabolites Against Fluconazole-Resistant Oral Candida albicans: In vitro Evaluation and Mechanistic Insights},
journal = {Iranian Biomedical Journal},
year = {2025},
doi = {10.61882/ibj.4937}
}
EUVIMED